Actively Recruiting

Age: 2Years - 35Years
All Genders
ID04948658

Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency, and Clinically Indicated Gonadectomy

Led by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Updated on 2026-05-01

200

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying fertility challenges in individuals with Turner Syndrome, galactosemia, premature ovarian insufficiency (POI), and variations in sex characteristics. The study aims to understand why these conditions lead to early loss of ovarian function and whether freezing gonadal tissue can help preserve fertility for future use. The investigation includes examining the number and quality of follicles and gametes in the tissue and exploring the underlying biological reasons for follicle loss using advanced genetic sequencing techniques. Participants include children and adolescents aged 2 to 35 years who meet various condition-specific criteria. They may undergo medical history screening, physical exams, blood tests, body measurements, and ultrasound imaging. Some participants will have surgery to remove gonadal tissue, which will be frozen and stored for fertility preservation and used for research. The tissue storage is funded by NIH for one year, after which participants may be responsible for ongoing costs. Follow-up care includes checkups six weeks after surgery and periodic visits or phone calls for up to 30 years. During the study, participants will complete surveys about quality of life and health, and researchers will track hormone levels and analyze tissue samples before and after freezing. The study will monitor surgical outcomes and long-term effects of tissue freezing. Researchers will also develop a national database to better understand outcomes and explore treatments to improve follicle preservation. Participation involves extensive evaluations, long-term follow-up, and contributes to advancing knowledge on fertility preservation in these conditions.

CONDITIONS

Brief Title

Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy

Who Can Participate

Age: 2Years - 35Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Individuals with Turner Syndrome aged 2 to 12 years prior to menarche seeking ovarian tissue storage
  • Individuals with galactosemia aged 2 to 21 years
  • Females aged up to 21 years who have undergone menarche and were diagnosed with premature ovarian insufficiency within 2 years
  • Children or adolescents aged 2 to 24 years with diminished ovarian reserve or poor response to ovarian stimulation for egg freezing
  • Individuals with variations in sex characteristics (including Turner syndrome with Y chromosome material) undergoing prophylactic gonadectomy
  • Individuals aged 2 to 35 years receiving high-risk gonadotoxic therapy at the NIH Clinical Center
  • Willingness to comply with all study procedures and availability for the study duration
  • Ability to understand and sign informed consent or assent
Not Eligible

You will not qualify if you...

  • Individuals older than 7 years with psychological or psychiatric conditions preventing informed consent or assent
  • Individuals with pelvic mass tumors noted on pre-operative ultrasound who will receive usual care and not undergo gonadal tissue removal
  • Individuals with medical conditions that significantly increase risk from anesthesia or surgery
  • Females with premature ovarian insufficiency due to chemotherapy or radiation
  • Pregnancy or lactation
  • Individuals with variations in sex characteristics who choose to keep their gonads after clinical consultation
  • Individuals with Turner Syndrome who have undetectable anti-Mullerian hormone levels based on testing reference ranges

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery and Immediate Post-operative Care

Duration - 1 day

Participants undergo gonadectomy or gonadal tissue removal for fertility preservation and tissue collection for research.

1 surgery visit and immediate post-operative observation

Post-operative Follow-up

Duration - Up to several weeks post-surgery

Participants are monitored for surgical recovery and any complications following tissue removal.

Approximately 2 to 3 follow-up visits

Tissue Analysis and Research

Duration - Ongoing during and after tissue collection

Collected gonadal tissue is analyzed before and after cryopreservation to evaluate follicle and gamete quality, and research studies are conducted including next generation sequencing and treatment with inhibitors and activators.

No participant visits required during this stage

Trial Site Locations

Total: 1 location

1

National Institutes of Health Clinical Center

Bethesda, Maryland, United States, 20892

Actively Recruiting

Loading map...

Research Team

V

Veronica Gomez-Lobo, M.D.

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

6

Similar Trials

Bleeding Patterns in Sequential and Continuous Progesterone ...

Turner Syndrome

Actively Recruiting

1 location

Cardiopulmonary Exercise Testing in Girls (8-18y) with Turne...

Turner Syndrome

Actively Recruiting

1 location

Characterization of Hepatopathy in Turner Syndrome: Analysis...

Turner Syndrome

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion.

Ethics Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org

https://pubmed.ncbi.nlm.nih.gov/30098684

Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.

Francisca Martinez, International Society for Fertility Preservation–ESHRE–ASRM Expert Working Group

https://pubmed.ncbi.nlm.nih.gov/28739117

Ovarian stimulation and assisted reproductive technology outcomes in women transplanted with cryopreserved ovarian tissue: a systematic review.

Signe Taasti Andersen, Susanne Elisabeth Pors, Liv la Cour Poulsen...

https://pubmed.ncbi.nlm.nih.gov/31594631